| Literature DB >> 26940059 |
Kathy Han1, Akila N Viswanathan2.
Abstract
Despite its established efficacy, brachytherapy is underused in the management of cervical and vaginal cancers in some parts of the world. Possible reasons for the underutilization of brachytherapy include the adoption of less invasive techniques, such as intensity-modulated radiotherapy; reimbursement policies favoring these techniques over brachytherapy; poor physician or patient access to brachytherapy; inadequate maintenance of brachytherapy skills among practicing radiation oncologists; transitioning to high-dose-rate (HDR) brachytherapy with increased time requirements; and insufficient training of radiation oncology residents.Entities:
Keywords: Brachytherapy; Cervical cancer; Gynecologic cancer; Intensity-modulated radiotherapy; Utilization; Vaginal cancer
Mesh:
Year: 2016 PMID: 26940059 DOI: 10.1007/s11912-016-0508-y
Source DB: PubMed Journal: Curr Oncol Rep ISSN: 1523-3790 Impact factor: 5.075